A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 158 participants.
Also called NCT02156076
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 158 participants
- Sponsor
- Registry
-
NCT02156076
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Terminated
Technical summary
Registry record NCT02156076. Randomized; quadruple masking; primary purpose other. Start 2014-07-25 (actual); primary completion 2016-06-01 (actual). Results posted on 2019-05-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Drug)
- BMS-919373
- Intervention (Drug)
- Placebo (Matching with BMS-919373)
- Lead sponsor
- Bristol-Myers Squibb
Record details
- Record id
cardio:ct-nct02156076- Content hash
2e51c267d7ea8c2b34b93293bf2b91cca06ea72726026d6cd518b7d25d1d04fb